Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cell Cycle (Georgetown, Tex.)
|
July 24, 2007
Bub1: escapades in a cellular world
Grace L Williams, Thomas M Roberts, Ole V Gjoerup
Proceedings of the National Academy of Sciences of the United States of America
|
May 10, 2007
Surveillance mechanism linking Bub1 loss to the p53 pathway
Ole V Gjoerup, Jiaping Wu, Devin Chandler-Militello, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2004
Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1
Marina Cotsiki, Rowena L Lock, Yuan Cheng, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2017
Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains
David S Millan, Katherine J Kayser-Bricker, Matthew W Martin, et al.
Targeted Oncology
|
February 24, 2023
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
Maureen Caligiuri, Grace L Williams, Jennifer Castro, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cell Cycle (Georgetown, Tex.)
|
July 24, 2007
Bub1: escapades in a cellular world
Grace L Williams, Thomas M Roberts, Ole V Gjoerup
Proceedings of the National Academy of Sciences of the United States of America
|
May 10, 2007
Surveillance mechanism linking Bub1 loss to the p53 pathway
Ole V Gjoerup, Jiaping Wu, Devin Chandler-Militello, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2004
Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1
Marina Cotsiki, Rowena L Lock, Yuan Cheng, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2017
Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains
David S Millan, Katherine J Kayser-Bricker, Matthew W Martin, et al.
Targeted Oncology
|
February 24, 2023
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
Maureen Caligiuri, Grace L Williams, Jennifer Castro, et al.
Page
of 1